-
Cost-Effectiveness of a Hypothetical Dementia Prevention Treatment for Stroke Survivors
Mar 10, 2025, 14:00 PM -
Trends in FDA Approvals of Cardiovascular Drugs from 1980 to 2024
Mar 10, 2025, 14:00 PM -
Costs of Alzheimer's Disease and Related Dementia among Medicare Beneficiaries in the United States
Mar 10, 2025, 14:00 PM -
Baseline Risk of Hospitalization and Mortality in High-Risk Subgroups of a Nirmatrelvir/Ritonavir Treatment-Eligible Population With Mild-to-Moderate COVID-19 in the United States: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Perspectives of Adult Patients and Caregivers on the Management and Challenges Associated With Neurofibromatosis Type 1 and Plexiform Neurofibroma: A Multinational, Qualitative Study
Mar 10, 2025, 14:00 PM -
Economic Burden of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D), Considering the Costs of Cardiovascular Hospitalization Events in Colombia
Mar 10, 2025, 14:00 PM -
Acute Care visits and Readmissions Among Commercial Plan Enrollees with Heart Failure with Preserved Ejection Fraction (HFpEF) by Obesity Classes
Mar 10, 2025, 14:00 PM -
Developing a Value Assessment Framework for Modified New Drugs In China
Mar 10, 2025, 14:00 PM -
Assessing the Economic Impact of Biosimilars in the U.S.: A cost analysis of Infliximab, Trastuzumab, and Rituximab
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Pembrolizumab for Previously treated MSI-H/dMMR Solid Tumors in Canada
Mar 10, 2025, 14:00 PM -
Real-World Healthcare Resource Utilization (HCRU) and Economic Burden Among Patients With High-Risk Carcinoma-In-Situ (CIS) Non-Muscle Invasive Bladder Cancer (NMIBC) Using a Large Medicare Dataset
Mar 10, 2025, 14:00 PM -
Predicting Future Type 1 Diabetes Onset Risk; A Machine Learning Approach
Mar 10, 2025, 14:00 PM -
Real-World Adjuvant Nivolumab Utilization in Surgically Treated Muscle-Invasive Bladder Cancer Patients within U.S. Community Oncology Practice
Mar 10, 2025, 14:00 PM -
Benchmarking Disease Prevalence in a Large Scale Electronic Health Record Data Network: An Assessment of Chronic and Rare Disease in the United States in 2023
Mar 10, 2025, 14:00 PM -
Association Between Vaginal Progesterone Use and Risk of Preterm Birth Among High-Risk Pregnancies: A Real-World Evidence Study
Mar 10, 2025, 14:00 PM -
Real-world Clinical And Demographic Characteristics Associated With Progression To Type 2 Diabetes In Patients With Prediabetes
Mar 10, 2025, 14:00 PM -
The Cost of 340B to States
Mar 10, 2025, 14:00 PM -
Population Impact Model of Faricimab and Aflibercept 8mg among US patients with Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
Mar 10, 2025, 14:00 PM -
Comparative Risk of Major Adverse Cardiovascular Events among Patients who Initiate Treatment with Acute Migraine Agents
Mar 10, 2025, 14:00 PM -
Economic Burden of Opioid-Induced Constipation Among Patients With or Without Cancer in the United States
Mar 10, 2025, 14:00 PM